AbbVie Inc.

ABBV | NYSE

Price Alert Chart Builder DCF Calculator

$266.14

+$1.66 (+0.63%)

Sep 22, 2026, 12:43 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	61.16B	56.33B	54.32B	58.05B	56.2B	45.8B
Cost of Revenue	18.2B	16.9B	20.42B	17.41B	17.45B	15.39B
Gross Profit	42.96B	39.43B	33.9B	40.64B	38.75B	30.42B
Operating Income	20.09B	9.14B	12.76B	18.12B	17.92B	11.36B
Interest Income	266M	648M	540M	186M	39M	174M
Pretax Income	6.6B	3.72B	6.25B	13.48B	12.99B	3.4B
Net Income	4.23B	4.28B	4.86B	11.84B	11.54B	4.62B
Selling & General & Admin	14.01B	14.75B	12.87B	15.26B	12.35B	11.3B
Research & Development	9.1B	12.79B	7.68B	6.51B	8.05B	7.76B
Other Expenses	-241M	2.75B	599M	753M	432M	n/a
Operating Expenses	22.87B	30.29B	21.15B	22.52B	20.83B	19.05B
Interest Expense	2.89B	2.81B	2.22B	2.23B	2.42B	2.45B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	41.07B	47.2B	41.56B	39.94B	38.27B	34.44B
Income Tax Expense	2.36B	-570M	1.38B	1.63B	1.44B	-1.22B
Shares Outstanding (Basic)	1.77B	1.77B	1.77B	1.77B	1.77B	1.67B
Shares Outstanding (Diluted)	1.77B	1.77B	1.77B	1.78B	1.78B	1.67B
EPS (Basic)	2.37	2.40	2.73	6.65	6.48	2.73
EPS (Diluted)	2.37	2.39	2.72	6.63	6.45	2.72
EBITDA	17.63B	14.91B	17.17B	24.17B	23.93B	12.32B
EBIT	9.49B	6.52B	8.47B	15.71B	15.41B	5.85B
Depreciation & Amortization	8.14B	8.39B	8.7B	8.47B	8.52B	6.47B